Catalyst Funds Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,000
Closed -$58.3K 586
2024
Q3
$58.3K Buy
+2,000
New +$58.3K 0.01% 731